Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 43 trials | ||||||
| Phase 4 | NCT04500015 | Sep 2020 → Jun 2021 | uterine inflammatory disease | Aswan University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04499976 | Sep 2020 → Apr 2021 | — | Aswan University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT04500028 | Aug 2020 → Oct 2021 | uterine inflammatory disease | Aswan University Hospital | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT04500470 | Sep 2020 → Jul 2021 | female infertility | Aswan University Hospital | Completed | No outcome recorded |
| — | NCT04505943 | Sep 2020 → Jul 2021 | uterine inflammatory disease | Aswan University Hospital | Unknown | No outcome recorded |
| — | NCT04500002 | Sep 2020 → Jun 2021 | uterine inflammatory disease | Aswan University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Isonicotinic Acid Hydrazide | “Adjuvant Isonicotinic Acid Hydrazide (INH) With Misoprostol for Induction of Abortion in First-trimester Missed Miscarriage Among Women With One or More Previous Cesarean...” NCT04499976 ↗5“Benefits of Self-administered Vaginal Isonicotinic Acid Hydrazide (INH) Administration 12 Hours Prior to Intrauterine Device Insertion in Adolescent and Young Women: a...” NCT04500015 ↗ “vaginal isonicotinic acid hydrazide (INH) administered before the levonorgestrel-releasing intrauterine system(IUs) insertion reduces failed insertions” NCT04500028 ↗ “900 mg vaginal isonicotinic acid hydrazide by the patient 12 hours before the procedure” NCT04500470 ↗ |
| Known as | INH | “Adjuvant Isonicotinic Acid Hydrazide (INH) With Misoprostol for Induction of Abortion in First-trimester Missed Miscarriage Among Women With One or More Previous Cesarean...” NCT04499976 ↗4“Benefits of Self-administered Vaginal Isonicotinic Acid Hydrazide (INH) Administration 12 Hours Prior to Intrauterine Device Insertion in Adolescent and Young Women: a...” NCT04500015 ↗ “Adjuvant Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol for Induction of Abortion in First-trimester Missed Miscarriage: A Randomized Controlled Trial” NCT04500002 ↗ “vaginal isonicotinic acid hydrazide (INH) administered before the levonorgestrel-releasing intrauterine system(IUs) insertion reduces failed insertions” NCT04500028 ↗ “Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide (INH) Prior to Hysterosalpingography” NCT04500470 ↗ |